Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19
Journal article
Luo J. et al, (2021), Allergy, Asthma & Clinical Immunology, 17
The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D2 Production Are Attenuated by PGD2 Receptor 2 Antagonism
Journal article
Chen W. et al, (2021), The Journal of Immunology, 206, 2714 - 2724
Resistance to apoptosis underpins corticosteroid-insensitivity of group 2 innate lymphoid cells.
Journal article
Luo J. et al, (2019), J Allergy Clin Immunol
Correction: Synergistic activation of pro-inflammatory type-2 CD8 + T lymphocytes by lipid mediators in severe eosinophilic asthma
Journal article
Hilvering B. et al, (2019), Mucosal Immunology, 12, 581 - 581
FEVIPIPRANT INHIBITS PROSTAGLANDIN D2 MEDIATED ACTIVATION OF GROUP 2 INNATE LYMPHOID CELLS (ILC2S)
Conference paper
Sandham D. et al, (2019), RESPIROLOGY, 24, 105 - 105
Fevipiprant, a Selective Prostaglandin D(2)Receptor 2 Antagonist, Potently Inhibits Chemotaxis and Cytokine Production by Tc2 cells (type-2 CD8(+)lymphocytes)
Conference paper
Xue L. et al, (2019), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 199
Effects of Steroids in Cultured Human Type-2 Cytokine Producing Cells
Conference paper
Luo J. et al, (2018), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197
The Effect of Oral Corticosteroids on Circulating Type-2 Cytokine Producing Cells in Patients with Severe Eosinophilic Asthma
Conference paper
Hynes G. et al, (2018), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
Conference paper
Chen W. et al, (2018), EUROPEAN RESPIRATORY JOURNAL, 52
Type-2 CD8+ T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma
Conference paper
Hinks T. et al, (2018), Airway Cell Biology and Immunopathology
Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma
Journal article
Hilvering B. et al, (2018), Mucosal Immunology, 11, 1408 - 1419
Fevipiprant, a Selective Prostaglandin D-2 Receptor 2 Antagonist, Potently Inhibits Chemotaxis and Cytokine Production by Group 2 Innate Lymphoid Cells
Conference paper
Xue L. et al, (2018), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197
Novel data analysis method for multicolour flow cytometry links variability of multiple markers on single cells to a clinical phenotype.
Journal article
Tinnevelt GH. et al, (2017), Scientific Reports, 7, 5471 - 5471
Sputum Il-17a Levels Correlate With Biomarkers Of Non-Eosinophilic Inflammation In Patients With Asthma
Conference paper
Hynes G. et al, (2017), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 195
Interaction Of Type 2 Cytotoxic T Lymphocytes And Mast Cell Lipid Mediators Contributes To Pathogenesis Of Eosinophilic Asthma
Conference paper
Xue L. et al, (2017), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 195
Type 2 Cytotoxic T Lymphocytes In Patients With Severe Eosinophilic Asthma
Other
Xue L. et al, (2017), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 195
Diagnosing eosinophilic asthma using a multivariate prediction model based on blood granulocyte responsiveness.
Journal article
Hilvering B. et al, (2016), Allergy
SPUTUM CYTOKINES AND CLINICAL BIOMARKERS IN SEVERE ASTHMA
Other
Shrimanker R. et al, (2016), THORAX, 71, A214 - A214
Neutrophil Death In A Population Of Patients With Neutrophilic COPD
Conference paper
Cane JL. et al, (2016), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 193
Peripheral Blood Crth2 Positive Cells In Patients With Severe Asthma
Conference paper
Xue L. et al, (2016), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 193